Exclusive: Roche exploring sale of diabetes device unit

By Jessica Toonkel NEW YORK (Reuters) – Swiss drugmaker Roche Holding AG is exploring a sale of its blood glucose meters business, three people familiar with the matter told Reuters on Wednesday, as the industry grapples with increased competition and reimbursement pressure. The discussions about a potential sale of the Roche unit are still in their early stages and a deal may not materialize, one of the people said. Earlier this year, the Centers for Medicare & Medicaid Services announced it was cutting the reimbursement for diabetes test supplies by up to 72 percent. …